期刊
FRONTIERS IN NEUROSCIENCE
卷 16, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fnins.2022.957667
关键词
TXNIP (thioredoxin-interacting protein); diabetic retinal neurodegeneration; diabetic retinopathy; thioredoxin; TXNIP modulators
资金
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
- Liaoning Provincial Program for Top Discipline of Basic Medical Sciences
- [31371218]
- [2020-BS-189]
Diabetic retinal neurodegeneration (DRN) occurs prior to retinal microvascular alterations and is associated with neuronal apoptosis, a decrease in optic nerve axons, and reactive gliosis. Thioredoxin-interacting protein (TXNIP) plays a significant role in DR and is involved in the regulation of multiple signaling pathways.
Diabetic retinopathy (DR) is a common complication of diabetes mellitus and has been considered a microvascular disease for a long time. However, recent evidence suggests that diabetic retinal neurodegeneration (DRN), which manifests as neuronal apoptosis, a decrease in optic nerve axons, and reactive gliosis, occurs prior to retinal microvascular alterations. Thioredoxin-interacting protein (TXNIP) is an endogenous inhibitor of thioredoxin (Trx), and it acts by inhibiting its reducing capacity, thereby promoting cellular oxidative stress. In addition, it participates in regulating multiple signaling pathways as a member of the alpha-arrestin family of proteins. Accumulating evidence suggests that TXNIP is upregulated in diabetes and plays a pivotal role in the pathophysiological process of DR. In this review, we summarized the role of TXNIP in DRN, aiming to provide evidence for DR treatment in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据